Rapport Therapeutics director Ramiro Sanchez reports purchase of $98,477.64 in common shares
RAPP•Director Ramiro Sanchez purchased 3,600 Rapport Therapeutics common shares at $27.3549 each, bringing his direct holdings to 3,600 shares.
1. Share purchase
Rapport Therapeutics director Ramiro Sanchez purchased 3,600 common shares at $27.3549 per share. His direct holdings totaled 3,600 shares following the purchase.
